Skip to main content

A patent infringement case is pushing for Apple to stop selling its two most recent Apple Watch models, the Series 9 and Ultra 2.

A ban came and went in December, but the court lifted its stay, so the new watches are once again banned from the US if they have the disputed blood oxygen technology. Apple has announced that new versions of the Series 9 and Ultra 2 without those features will go on sale in the morning on Thursday, January 18th.

The move came in response to an import ban handed down by the US International Trade Commission, which ruled in October that Apple infringed on patents for pulse oximetry tech made by Masimo, a medical device maker. This would mean Apple can no longer import and sell its newest Apple Watch models in the US. The company is already trying to come up with a solution to avoid the ban, but it might take a while until the dispute is completely resolved.

If you want to keep up with all the latest on Apple’s legal battle, check out the news below.

  • Terrence O'Brien

    Terrence O'Brien

    Apple hit with $634 million verdict in patent battle with Masimo.

    A federal jury in California sided with medical tech company Masimo in its suit alleging that the Apple Watch infringed on its patent covering low-power pulse oximeter features. The victory hinged on the definition of the term “patient monitor,” which Apple argued only applied to devices that provided continuous monitoring, while the Apple Watch’s blood oxygen features only kick in after 10 minutes of inactivity. This case is separate from the one working its way through the ITC.

  • Jess Weatherbed

    Jess Weatherbed

    Now Masimo is suing US Customs over Apple Watch imports

    Close up of the black Apple Watch Ultra 2
    Close up of the black Apple Watch Ultra 2
    Masimo isn’t happy about the CBP reversing its previous Apple Watch import ban.
    Photo by Amelia Holowaty Krales / The Verge

    Medical tech company Masimo is suing US Customs and Border Protection (CBP) in an attempt to overturn the agency’s decision to allow Apple to restore the blood oxygen tracking feature on Apple Watches. Masimo said it only learned that the ban had been reversed after Apple announced a “redesigned” pulse oximetry feature last week, which calculates blood oxygen levels on iPhones instead of the Watch.

    Apple has been embroiled in legal disputes over Masimo’s blood oxygen sensor patent since 2020, disabling the feature on supported US Apple Watch models following an ITC import ban in December 2023. In a complaint filed on Wednesday, Masimo said that the CBP failed to notify the company of its decision to reverse the International Trade Commission restrictions, leaving Masimo with no opportunity to review or challenge the ruling.

    Read Article >
  • Richard Lawler

    Richard Lawler

    Apple releases iOS 18.6.1 and watchOS 11.6.1 with the new Blood Oxygen experience.

    As announced Thursday morning, Apple has now released new iPhone and Watch updates that re-enable the Blood Oxygen monitoring feature in the US for Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 users as a workaround for the ITC’s import ban.

    Screenshot of tweet from Apple’s Greg Joswiak saying “As part of our ongoing goal to help you live a healthier life, we launched a redesigned Blood Oxygen feature for Apple Watch Series 9, Series 10, and Ultra 2 users in the US today!Download the latest software to try it out.”
    Screenshot: Greg Joswiak (X)
  • Victoria Song

    Victoria Song

    Apple returns blood oxygen monitoring to the latest Apple Watches

    The update will be available today for Series 9, 10 and Ultra 2 owners in the U.S.
    The update will be available today for Series 9, 10 and Ultra 2 owners in the U.S.
    The update will be available today for Series 9, 10 and Ultra 2 owners in the U.S.
    Photo by Amelia Holowaty Krales / The Verge

    Blood oxygen monitoring is returning to the Apple Watch — sort of. Starting today, Apple is rolling out a software update that enables a redesigned version of the feature for the Apple Watch Series 9, 10, and Ultra 2 that circumvents the import ban imposed by the International Trade Commission.

    To get around the ban, blood oxygen data collected on the Watch will now be measured and calculated on the iPhone that it’s paired to. While users won’t be able to view the data on their wrist, they’ll be able to view it in the iPhone’s Health app under the Respiratory section. Apple’s announcement states that US customs has ruled that the company will be able to import watches with this redesigned feature.

    Read Article >
  • Jay Peters

    Jay Peters

    Masimo has a new CEO.

    The company, whose patent infringement claim led Apple to remove blood oxygen sensing tech from newer Apple Watches, has named Katie Szyman, worldwide president of Advanced Patient Monitoring at Becton Dickinson, for the role, The Wall Street Journal reports.

    Interim CEO Michelle Brennan, who took over after CEO Joe Kiani resigned, will become the chair of Masimo’s board.

  • Jay Peters

    Jay Peters

    Apple wins a battle (and $250) in its smartwatch patent fight with Masimo

    Vector illustration of the Apple logo.
    Vector illustration of the Apple logo.
    Image: Cath Virginia / The Verge

    Apple got a mixed victory in a patent infringement lawsuit against medical device maker Masimo. On Friday, a federal jury determined that Masimo had infringed on some Apple patents, and as part of the verdict, Apple was awarded $250 — yes, just $250 — as a statutory remedy for Masimo’s infringement.

    $250 is the statutory minimum damages for the alleged infringement and Apple had sought that figure, Bloomberg Law reports. “We’re not here for the money,” Apple attorney John Desmarais said to jurors in closing arguments, according to the publication.

    Read Article >
  • Richard Lawler

    Richard Lawler

    Masimo CEO Joe Kiani has resigned.

    The company with the blood oxygen sensing tech causing issues for Apple Watches has announced its CEO — who we just interviewed — is out after investors voted to remove him from the board amid a proxy battle with Politan Capital Management.

    In a filing, Masimo said Kiani filed a claim against the company in California state court related to his employment agreement. Michelle Brennan has been appointed interim CEO.

  • Richard Lawler

    Richard Lawler

    The company blocking blood oxygen features on Apple Watch has new deals with Google and Qualcomm.

    Pulse oximetry features were recently removed from new Apple Watches due to Masimo’s patent infringement claim. Now the medical device maker has announced deals with Qualcomm and Google for Wear OS reference platforms.

    They say that OEMs who use them will design the wearables exteriors and software, but with internal hardware, software, and sensors designed/tested by Masimo.

    The Masimo W1 and Freedom protoype side by side on a table.
    Masimo’s W1 wearable along with a prototype of its Freedom wearable, which will use Qualcomm hardware.
    Photo by Victoria Song / The Verge
  • Victoria Song

    Victoria Song

    Here’s Apple’s 916-page appeal over the Apple Watch ban

    Pink Series 9 on a reflective pink surface.
    Pink Series 9 on a reflective pink surface.
    Apple’s not too happy that Masimo’s W1 watch didn’t exist when Masimo filed its complaint.
    Photo by Amelia Holowaty Krales / The Verge

    There was no question that Apple would appeal when the International Trade Commission banned Apple Watch Series 9 and Ultra 2 sales last year. Well, if you’ve got some time, you can now read all 916 pages of Apple’s appeal to the Federal Circuit.

    A quick recap: the Apple Watch ban centers around whether Apple infringed upon medical device-maker Masimo’s pulse oximetry patents. The ITC sided with Masimo, concluding that Apple had infringed their patents, and that the infringement was harming domestic industry.

    Read Article >
  • Emma Roth

    Emma Roth

    How Apple’s lobbyists are trying to make getting an ITC import ban even harder.

    The New York Times reports on the campaign pushing the US International Trade Commission “to put the public interest of a product ahead of a ban.”

    Apple tried avoiding its Watch Series 9 and Watch Ultra 2 import ban late last year by arguing it would have a “detrimental” effect on users. However, the ITC denied this request, saying “public interest favors the protection of intellectual property rights by excluding infringing products.”

  • Wes Davis

    Wes Davis

    Masimo jailbroke iPhones to try to keep the Apple Watch banned.

    That’s according to the US Customs and Border Protection’s (CBP) recently-published January 12th ruling that approved Apple’s modification meant to lift the Apple Watch ban.

    CBP chief Dax Terrill wrote that Masimo installed “otherwise restricted software that, but for the jailbreaking, would not have been feasible.” He concluded that the software change “would appear to resolve the issue of infringement.”

  • Victoria Song

    Victoria Song

    Tim Cook nixes the idea of licensing Masimo’s blood oxygen tech.

    Despite mixed earnings, Tim Cook doesn’t seem to be sweatin’ the Apple Watch ban. Apple Insider spotted Cook telling CNBC on a live broadcast that it’s “focused on appeal” and that customers have “lots of reasons to buy the watch even without the blood oxygen sensor.”

    Masimo CEO Joe Kiani has publicly said he hasn’t heard from Apple about potentially licensing the company’s blood oxygen tech. However, this is the first time we’ve seen Cook officially confirming it.

  • Wes Davis

    Wes Davis

    You might want to be extra careful with your pre-ban Apple Watch.

    If you got a Series 9 or Ultra 2 before Apple had to remove the blood oxygen feature from new ones on January 17th, congrats!

    But if you break your watch doing parkour and replace it with AppleCare, will you lose the feature? That’s a “definite maybe,” according to Bloomberg’s Mark Gurman. He wrote today in the subscriber version of Power On that Apple has told AppleCare reps that replacements might not have it.

  • Jay Peters

    Jay Peters

    “Apple Watch Series 9 and Ultra 2 no longer include the blood oxygen feature.”

    Following yesterday’s news, that’s the text now shown at the top of Apple’s Series 9 and Ultra 2 websites.

    A screenshot of the Apple Watch Ultra 2 website. A banner at the top says “Apple Watch Series 9 and Ultra 2 no longer include the blood oxygen feature.”
    Screenshot by Jay Peters / The Verge
  • Jay Peters

    Jay Peters

    Apple Watches without banned blood oxygen features are now on sale

    An Apple Watch Ultra 2 and the bottom of an Apple Watch Series 9.
    An Apple Watch Ultra 2 and the bottom of an Apple Watch Series 9.
    Photo by Victoria Song / The Verge

    Following a lost bid to halt a ban on selling its newest Apple Watches, Apple started selling the Apple Watch Series 9 and Apple Watch Ultra 2 online and in Apple Stores without blood oxygen measuring features on January 18th. A footnote on Apple’s site tells you how to identify the newer watches:

    Apple spokesperson Nikki Rothberg sent over a statement (included below) as well as information from Apple on how these devices will work. On these watches, the blood oxygen icon will still appear, but if the user taps it, they’ll see a message reading, “The Blood Oxygen app is no longer available. Learn more in the Health app on your iPhone.” In the Health app, blood oxygen is listed as “unavailable,” with a link pointing to a support article on Apple.com.

    Read Article >
  • Victoria Song

    Victoria Song

    Apple Watches with blood oxygen tech are banned again

    The Apple Watch Ultra 2 on grass.
    The Apple Watch Ultra 2 on grass.
    Photo by Amelia Holowaty Krales / The Verge

    Update January 17th, 8:52PM ET: Apple has confirmed that versions of the Apple Watch Series 9 and Ultra 2 without blood oxygen features will go on sale starting January 18th at 9AM ET. Our original story continues below.

    In the latest twist in Apple’s ongoing patent battle with Masimo, the US Court of Appeals for the Federal Circuit has denied extending an interim stay on the Apple Watch ban. That means Apple will once again have to stop selling its Apple Watch Series 9 and Ultra 2 devices that have the technology enabled starting at 5PM ET on January 18th.

    Read Article >
  • Emma Roth

    Emma Roth and Alex Cranz

    Apple Watch drops blood oxygen features to dodge the import ban

    Apple Watch Series 9 with Siri pulled up
    Apple Watch Series 9 with Siri pulled up
    Photo by Amelia Holowaty Krales / The Verge

    The blood oxygen feature is about to disappear from new Apple Watch Series 9 and Watch Ultra 2 devices. While Apple itself has not released a statement or responded to our request for comment, both Bloomberg and 9to5Mac are reporting that the feature will be going away and that US Customs and Border Protection has approved the measure, which would allow Apple to consider selling both products after their sale was banned last year.

    The Apple Watch Series 9 and Watch Ultra 2 were both banned in the US late last year as the result of a patent dispute with medical device maker Masimo. The International Trade Commission (ITC) ruled that the blood oxygen sensors in both devices infringed on patents from Masimo.

    Read Article >
  • Jess Weatherbed

    Jess Weatherbed

    Apple’s Watch workaround to avoid an import ban has reportedly been approved.

    Word of this comes not from US Customs, but Masimo’s own lawyers in a letter published by 9to5Mac. It says the updated watches “do not contain pulse oximetry functionality,” which is a step further than last month’s report that Apple engineers were working on new algorithms.

    It means Apple can continue importing the Apple Watch Series 9 and Apple Watch Ultra 2 despite the patent infringement dispute — just without blood oxygen reading features enabled.

  • Victoria Song

    Victoria Song

    Why the ITC denied staying the Apple Watch ban.

    The ITC’s opinion on the Apple Watch ban has been unsealed. You can read it at the link below, but there are no big surprises. The gist is the ITC didn’t think Apple proved it would suffer irreparable harm if the ban went through.

    But the saga isn’t over yet. Shortly after the ban went into effect, a federal appeals court issued a temporary pause, meaning you can still buy the Series 9 and Ultra. Right now, Apple’s waiting to hear back if proposed changes to the Apple Watch will render this patent beef moot.

    ITC Apple opinion

    [DocumentCloud]

  • Wes Davis

    Wes Davis

    Masimo kept winning on the way to its Apple Watch fight.

    My colleague Emma Roth recently wrote about how the company’s patent fight with True Wearables helps explain Masimo’s confidence in its Apple Watch fight.

    In a profile of Joe Kiani today, The Wall Street Journal writes about still more examples. One 2016 win gave Masimo a $300 million dollar payout from Philips and a deal that “ended up generating more than $1 billion” for the company. Before that, Masimo won “nearly $800 million” in “damages and royalties” from Nellcor.

  • Emma Roth

    Emma Roth

    Why Masimo thought it could take on Apple

    Close-up of Wayfinder watchface
    Close-up of Wayfinder watchface
    Photo by Amelia Holowaty Krales / The Verge

    For over three years now, Apple has been entrenched in a messy legal battle over a single feature on the Apple Watch — and Apple’s opponent, medical device maker Masimo, seems confident it can win. And there’s a good reason Masimo might believe that: the company came out on top when it sued True Wearables, a startup run by a former executive with a stint on the Apple Watch team, on similar grounds.

    In 2018, Masimo filed a complaint against True Wearables over claims its wireless pulse oximeter infringed on Masimo’s patent. The court sided with Masimo and issued a permanent injunction against the sale of the device in December 2022.

    Read Article >
  • Emilia David

    Emilia David

    Apple is now selling Apple Watches on its website again

    Person looking at interval workout on Apple Watch Ultra 2
    Person looking at interval workout on Apple Watch Ultra 2
    Photo by Victoria Song / The Verge

    Apple has resumed selling the latest Apple Watches on its website after a federal appeals court paused a sales and import ban.

    The Apple Watch Series 9 and Ultra 2 are now once again available on Apple’s website, a day after some physical Apple stores began selling the watches on December 27th. Apple previously told The Verge that the watches should be available widely in its physical stores by Saturday.

    Read Article >
  • Jacob Kastrenakes

    Jacob Kastrenakes

    Apple resumes Apple Watch sales after ban is paused

    Double tap gesture menu on Series 9
    Double tap gesture menu on Series 9
    Photo by Amelia Holowaty Krales / The Verge

    You can once again buy the latest Apple Watches straight from Apple. The Apple Watch Series 9 and Ultra 2 will be available again in some physical Apple stores starting today, with wider availability expected by Saturday. Online sales will resume tomorrow by 3PM ET, Apple spokesperson Nikki Rothberg told The Verge.

    The restarting of sales comes hours after a federal appeals court paused a sales and import ban that covered both devices. Apple was banned from selling both products in the US after the US International Trade Commission found that the company had violated patents from the medical device maker Masimo.

    Read Article >
  • Jacob Kastrenakes

    Jacob Kastrenakes

    Apple Watch ban temporarily paused

    Iphone moving message in Precision Finding feature on the screen
    Iphone moving message in Precision Finding feature on the screen
    Photo by Amelia Holowaty Krales / The Verge

    Apple has won a temporary pause of the Apple Watch ban that went into effect on Tuesday, so it will resume sales in Apple Stores starting today (Wednesday) and on Apple.com by 3PM ET / 12PM ET tomorrow, December 28th. A federal appeals court ordered a halt on the import and sales bans today, after Apple requested that they be paused at least until US Customs can determine if changes it’s making to the Apple Watch would be enough to avoid the patent dispute that led to the ban. Customs is expected to issue its decision on January 12th.

    The court’s order means that Apple can resume selling the Apple Watch Series 9 and Apple Watch Ultra 2 for the moment. Both watches were pulled from its website last week and off of store shelves this week, as the ban went into effect.

    Read Article >
  • Richard Lawler

    Richard Lawler

    Meet Marcelo Lamego, a key figure in the patent battle that’s banned Apple watches.

    Bloomberg reporter Mark Gurman goes into the history of Masimo’s patent infringement case against Apple’s wearables, explaining that Lamego was the CTO at a Masimo spinoff. He rebuffed one inquiry from Apple, but in 2013 he emailed Apple CEO Tim Cook at 1AM about working there and joined a few months later:

    Lawyers for Masimo say that Lamego lacked prior knowledge about how to develop the blood-oxygen feature (his previous studies were about neural interfaces rather than health sensors). He learned how to build the technology at Kiani’s companies and delivered it to Apple, they say.

    Lamego then resigned from Apple in July 2014, just months after joining. Masimo argues that he left after Apple got what it needed.

    Masimo also says Apple hired its former chief medical officer and 20 or so other staffers, while Apple claims he wasn’t a good fit.

More Stories